Signaling pathways responsible for the rapid antidepressant-like effects of a GluN2A-preferring NMDA receptor antagonist
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2158-3188
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Signaling pathways responsible for the rapid antidepressant-like effects of a GluN2A-preferring NMDA receptor antagonist ; volume:8 ; number:1 ; day:18 ; month:4 ; year:2018 ; pages:1-9 ; date:12.2018
Translational Psychiatry ; 8, Heft 1 (18.4.2018), 1-9, 12.2018
- Urheber
-
Gordillo-Salas, Marta
- Beteiligte Personen und Organisationen
- DOI
-
10.1038/s41398-018-0131-9
- URN
-
urn:nbn:de:101:1-2018062200490331263047
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:36 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Gordillo-Salas, Marta
- Pilar-Cuéllar, Fuencisla
- Auberson, Yves
- Adell, Albert
- SpringerLink (Online service)
Ähnliche Objekte (12)
Unmasking GluN1/GluN3A excitatory glycine NMDA receptors
Involvement of NMDA receptors containing the GluN2C subunit in the psychotomimetic and antidepressant-like effects of ketamine
Therapeutic potential of a novel NMDA receptor subunit GluN2B antagonist in a mouse model of autoimmune neuroinflammation
Untersuchungen zu molekularen Interaktions- und Inhibitionsmechanismen von GluN2A- und GluN2B-selektiven NMDA-Rezeptorantagonisten
Group II mGlu receptor antagonist LY341495 enhances the antidepressant-like effects of ketamine in the forced swim test in rats
Quinolone bioisosteres of phenolic GluN2B‐selective NMDA receptor antagonists
The non-NMDA glutamate receptor antagonist GYKI 52466 counteracts locomotor stimulation and anticataleptic activity induced by the NMDA antagonist dizocilpine
Traxoprodil, a selective antagonist of the NR2B subunit of the NMDA receptor, potentiates the antidepressant-like effects of certain antidepressant drugs in the forced swim test in mice
Synthese tricyclischer GluN2B-selektiver NMDA-Rezeptor-Antagonisten mit Benzimidazolon-Partialstruktur
GM-1020: a novel, orally bioavailable NMDA receptor antagonist with rapid and robust antidepressant-like effects at well-tolerated doses in rodents
Autodisplay der GluN1 und GluN2A Ligandenbindungsdomänen des NMDA-Rezeptors und Untersuchungen zur Membranintegration von Cholesterol-Derivaten
Benzol-Thiophen-Bioisosterie: GluN2B-selektive NMDA-Rezeptor-Antagonisten mit Thienoazepinol-Struktur
Unmasking GluN1/GluN3A excitatory glycine NMDA receptors
Involvement of NMDA receptors containing the GluN2C subunit in the psychotomimetic and antidepressant-like effects of ketamine
Therapeutic potential of a novel NMDA receptor subunit GluN2B antagonist in a mouse model of autoimmune neuroinflammation
Untersuchungen zu molekularen Interaktions- und Inhibitionsmechanismen von GluN2A- und GluN2B-selektiven NMDA-Rezeptorantagonisten
Group II mGlu receptor antagonist LY341495 enhances the antidepressant-like effects of ketamine in the forced swim test in rats
Quinolone bioisosteres of phenolic GluN2B‐selective NMDA receptor antagonists
The non-NMDA glutamate receptor antagonist GYKI 52466 counteracts locomotor stimulation and anticataleptic activity induced by the NMDA antagonist dizocilpine
Traxoprodil, a selective antagonist of the NR2B subunit of the NMDA receptor, potentiates the antidepressant-like effects of certain antidepressant drugs in the forced swim test in mice
Synthese tricyclischer GluN2B-selektiver NMDA-Rezeptor-Antagonisten mit Benzimidazolon-Partialstruktur
GM-1020: a novel, orally bioavailable NMDA receptor antagonist with rapid and robust antidepressant-like effects at well-tolerated doses in rodents
Autodisplay der GluN1 und GluN2A Ligandenbindungsdomänen des NMDA-Rezeptors und Untersuchungen zur Membranintegration von Cholesterol-Derivaten
Benzol-Thiophen-Bioisosterie: GluN2B-selektive NMDA-Rezeptor-Antagonisten mit Thienoazepinol-Struktur
Unmasking GluN1/GluN3A excitatory glycine NMDA receptors
Involvement of NMDA receptors containing the GluN2C subunit in the psychotomimetic and antidepressant-like effects of ketamine
Therapeutic potential of a novel NMDA receptor subunit GluN2B antagonist in a mouse model of autoimmune neuroinflammation
Untersuchungen zu molekularen Interaktions- und Inhibitionsmechanismen von GluN2A- und GluN2B-selektiven NMDA-Rezeptorantagonisten
Group II mGlu receptor antagonist LY341495 enhances the antidepressant-like effects of ketamine in the forced swim test in rats
Quinolone bioisosteres of phenolic GluN2B‐selective NMDA receptor antagonists
The non-NMDA glutamate receptor antagonist GYKI 52466 counteracts locomotor stimulation and anticataleptic activity induced by the NMDA antagonist dizocilpine
Traxoprodil, a selective antagonist of the NR2B subunit of the NMDA receptor, potentiates the antidepressant-like effects of certain antidepressant drugs in the forced swim test in mice
Synthese tricyclischer GluN2B-selektiver NMDA-Rezeptor-Antagonisten mit Benzimidazolon-Partialstruktur
GM-1020: a novel, orally bioavailable NMDA receptor antagonist with rapid and robust antidepressant-like effects at well-tolerated doses in rodents
Autodisplay der GluN1 und GluN2A Ligandenbindungsdomänen des NMDA-Rezeptors und Untersuchungen zur Membranintegration von Cholesterol-Derivaten